Burning Rock Biotech Stock Today

BNR Stock  USD 4.50  0.27  5.66%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Over 84

 
High
 
Low
Very High
Burning Rock is selling at 4.50 as of the 12th of September 2024; that is 5.66 percent decrease since the beginning of the trading day. The stock's lowest day price was 4.5. Burning Rock has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Burning Rock Biotech are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 14th of July 2024 and ending today, the 12th of September 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
12th of June 2020
Category
Healthcare
Classification
Health Care
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the Peoples Republic of China. The company was incorporated in 2014 and is headquartered in Guangzhou, China. Burning Rock operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. The company has 8.53 M outstanding shares of which 39.7 K shares are currently shorted by investors with about 10.8 days to cover. More on Burning Rock Biotech

Moving together with Burning Stock

  0.63ENTO Entero Therapeutics, Symbol ChangePairCorr

Moving against Burning Stock

  0.71VZ Verizon Communications Aggressive PushPairCorr
  0.71IBM International Business Fiscal Year End 22nd of January 2025 PairCorr
  0.67KO Coca Cola Fiscal Year End 11th of February 2025 PairCorr
  0.67PG Procter GamblePairCorr
  0.65TRV The Travelers Companies Fiscal Year End 17th of January 2025 PairCorr
  0.59JPM JPMorgan Chase Fiscal Year End 10th of January 2025 PairCorr

Burning Stock Highlights

ESG Sustainability
Environmental
Governance
Social
Thematic IdeaHealthcare (View all Themes)
Old Names[Two Shields Investments Plc, Brenntag SE, Burning Rock Biotech Limited]
Business ConcentrationBiotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, DAX Index, NASDAQ Composite, NASDAQ Health Care, HDAX Performance, DAX Price, HDAX Price, Healthcare, Health Care, Biotechnology, Diagnostics & Research, Healthcare (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.290.5168
Way Down
Slightly volatile
Gross Profit Margin0.550.6759
Significantly Down
Pretty Stable
Total Current Liabilities318.6 M263.4 M
Fairly Up
Pretty Stable
Non Current Liabilities Total7.8 M8.2 M
Notably Down
Slightly volatile
Total Assets1.6 BB
Way Up
Slightly volatile
Total Current Assets1.4 B884.1 M
Way Up
Slightly volatile
Debt Levels
Burning Rock can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Burning Rock's financial leverage. It provides some insight into what part of Burning Rock's total assets is financed by creditors.
Liquidity
Burning Rock Biotech has 12.32 M in debt with debt to equity (D/E) ratio of 0.05, which may show that the company is not taking advantage of profits from borrowing. Burning Rock Biotech has a current ratio of 3.99, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Note however, debt could still be an excellent tool for Burning to invest in growth at high rates of return.

Change In Working Capital

(54.76 Million)
Burning Rock Biotech (BNR) is traded on NASDAQ Exchange in USA. It is located in No. 5, Xingdao Ring Road North, Guangzhou, China, 510005 and employs 786 people. Burning Rock is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a total capitalization of 48.93 M. Burning Rock Biotech runs under Biotechnology sector within Health Care industry. The entity has 8.53 M outstanding shares of which 39.7 K shares are currently shorted by investors with about 10.8 days to cover. Burning Rock Biotech has about 1.15 B in cash with (255.78 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 10.95, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Burning Rock Probability Of Bankruptcy
Ownership Allocation
The market capitalization of Burning Rock Biotech is $48.93 Million. Over half of Burning Rock's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check Burning Ownership Details

Burning Stock Institutional Holders

InstituionRecorded OnShares
Ubs Group Ag2024-03-31
83.0
Blackrock Inc2024-06-30
6.0
Susquehanna International Group, Llp2024-06-30
0.0
D. E. Shaw & Co Lp2024-03-31
0.0
Ronald Blue Trust, Inc.2024-03-31
0.0
Dimensional Fund Advisors, Inc.2024-06-30
0.0
Sc China Holding Ltd2024-03-31
0.0
Lansdowne Partners Limited Partnership2024-03-31
0.0
Geode Capital Management, Llc2024-06-30
0.0
Kynam Capital Management, Lp2024-06-30
974.7 K
Massachusetts Financial Services Company2024-06-30
391.2 K
View Burning Rock Diagnostics

Burning Rock Historical Income Statement

At this time, Burning Rock's Tax Provision is relatively stable compared to the past year. As of 09/12/2024, Net Interest Income is likely to grow to about 16 M, while Interest Expense is likely to drop 0.00. View More Fundamentals

Burning Stock Against Markets

Burning Rock Corporate Management

Jinxiang LiCompliance CFOProfile
Yusheng HanChairman FounderProfile
Zhihong ZhangChief OfficerProfile
Shaokun ChuaiChief DirectorProfile
Hao LiuSenior AdvisorProfile

Additional Tools for Burning Stock Analysis

When running Burning Rock's price analysis, check to measure Burning Rock's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Burning Rock is operating at the current time. Most of Burning Rock's value examination focuses on studying past and present price action to predict the probability of Burning Rock's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Burning Rock's price. Additionally, you may evaluate how the addition of Burning Rock to your portfolios can decrease your overall portfolio volatility.